Download App
Help CenterSubscribe
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524412 NSE: AAREYDRUGS Trading | Small Cap | Aarey Drugs & Pharma Share Price

₹102.27 0.95 (0.94%)

As on 18-Sep'26 10:45

Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524412 NSE: AAREYDRUGS Trading | Small Cap | Aarey Drugs & Pharma Share Price

₹102.27 0.95 (0.94%)

As on 18-Sep'26 10:45

Key Metrics
Valuation Multiples
Market Cap
₹313 Cr.
Current Price
₹102.3
52-Week Low / High
₹50 / 103
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
38.6
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
19.19%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
37.71%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹30.9 Cr.
Face Value
₹10
All Time Low / High
₹0.50 / 143.95

Aarey Drugs & Pharmaceuticals stock performance

Key Ratios
mw4me loader

Check Before You Invest

Check Before You Invest

Quality

Not Good
Check detailed performance

Valuation

Overvalued

Check Valuation charts

Price Trend

Strong
Check Price chart
Q.1 Is Aarey Drugs & Pharmaceuticals Ltd a good quality company?
Aarey Drugs & Pharmaceuticals Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

View More

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

View More
How does Aarey Drugs & Pharmaceuticals Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Aarey Drugs & Pharmaceuticals Ltd vs industry peers?
Aarey Drugs & Pharmaceuticals Ltd revenue CAGR is %, compared to the industry median CAGR of 0.00%, indicating stable growth and maintaining its market share.
Q.1 Promoter shareholding and pledge status of Aarey Drugs & Pharmaceuticals Ltd?
Promoters hold 37.71% of the Aarey Drugs & Pharmaceuticals Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Aarey Drugs & Pharmaceuticals Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 9.2% based on the current price.
View More

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Aarey Drugs & Pharmaceuticals Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation ⓘ

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % ⓘ7.2%22.2%14.1%12.1%8.5%9.5%9.9%6.3%6.1%6.4%-
Value Creation
Index ⓘ		-0.50.60.0-0.1-0.4-0.3-0.3-0.6-0.6-0.5-

Growth Parameters ⓘ
Sales ⓘ246396349355300348493419398474415
Sales YoY Gr.-60.9%-12%1.7%-15.4%16.1%41.4%-15%-5.1%19.2%-
Adj EPS ⓘ0.832.62.82.52.82.61.61.71.41.4
YoY Gr.-297.4%-15.6%9.4%-11.1%12.1%-7.6%-37.4%3.7%-16.2%-
BVPS (₹) ⓘ21.826.633.33638.541.343.945.346.547.853
Adj Net
Profit ⓘ		1.35.566.55.86.56.54.14.744
Cash Flow from Ops. ⓘ5.70.6-20.40.72.95.50.5-1.3-310.3-
Debt/CF from Ops. ⓘ2.616.6-0.223.56.33.328.4-29.4-10.53.4-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘ7.6%9.6%-1.3%19.2%
Adj EPS ⓘ7%-10.8%-18.3%-16.2%
BVPSⓘ9.1%4.4%2.9%2.9%
Share Price 9.1% 22.6% 29.3% 37%

Key Financial Parameters ⓘ

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity % ⓘ		3.512.79.27.86.56.86.13.53.82.92.7
Op. Profit
Mgn % ⓘ		0.42.42.22.21.11.32.321.60.61.6
Net Profit
Mgn % ⓘ		0.51.41.71.81.91.91.311.20.81
Debt to
Equity ⓘ		0.40.200.20.20.20.10.30.20.3-
Working Cap
Days ⓘ		166112148147191209166221259215100
Cash Conv.
Cycle ⓘ		36246374543858836544

Valuation of Aarey Drugs & Pharma - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Financials

data not found
No data found!
data
No data found!
data
No data found!
data
No data found!

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Aarey Drugs & Pharmaceuticals Ltd FAQs

The current trading price of Aarey Drugs & Pharma on 18-Sep-2026 10:45 is ₹102.3.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 17-Sep-2026 the market cap of Aarey Drugs & Pharma stood at ₹312.8 Cr

The latest P/E ratio of Aarey Drugs & Pharma as of 17-Sep-2026 is 74.91.

The latest P/B ratio of Aarey Drugs & Pharma as of 17-Sep-2026 is 1.91.

The 52-week high of Aarey Drugs & Pharma is ₹102.8 and the 52-week low is ₹50.40.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Aarey Drugs & Pharma is ₹415 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Aarey Drugs & Pharmaceuticals Ltd is a below average quality company.

The key valuation ratios of Aarey Drugs & Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Aarey Drugs & Pharmaceuticals Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

About Aarey Drugs & Pharmaceuticals Ltd

Aarey Drugs & Pharmaceuticals Ltd. was established in 1990. The company is engaged in the manufacturing of drugs and intermediates such as metronidazole, metronidazole benzoate, methyl, and nitro imidazole. The company is based in Thane, India.

The  company also export its products to various other countries like Germany, Sri Lanka, Pakistan, Nepal and a number of African countries and is looking to establish its trade relations in other parts of the world as well.

Product range of the company includes: API/Intermediate

  • Metronidazol
  • Metronidazole Benzoate
  • 2 Methyl -5-Nitro Imidazole

Drug deliveryPharmaceuticals / Therapeutics

Therapeutic targets of the company's products are:

  • Allergy
  • Dermatology
  • Infectious Diseases

Recent development

Aarey Drugs & Pharmaceuticals  has recently informed that  Atul A Zatakia has resigned from the Company as a Director with effect from March 01, 2009.  

You have 47 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now